This most recent twist inside the Lykos Therapeutics saga threatens A significant overhaul of the corporation’s method and direction, with Musk ally and billionaire Trader Antonio Gracias showing up to desire to consider the business back towards its nonprofit drug advancement roots and a far more Doblinite philosophy.The claimed uses of copyrigh